Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,288 | -6,224 | -2,430 | -10,238 | -7,332 |
| Depreciation Amortization | 941 | 605 | 242 | 1,076 | 718 |
| Accounts receivable | 26 | -19 | 27 | 358 | 330 |
| Other Working Capital | 2,118 | 2,288 | 887 | 639 | 332 |
| Other Operating Activity | 583 | 19 | -27 | -246 | -288 |
| Operating Cash Flow | $-4,620 | $-3,331 | $-1,301 | $-8,411 | $-6,240 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 394 | N/A | 14 | 1,374 | 1,325 |
| PPE Investments | -28 | -26 | -10 | -221 | -260 |
| Other Investing Activity | 0 | 0 | 0 | -666 | 0 |
| Investing Cash Flow | $366 | $-26 | $4 | $487 | $1,065 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,633 | 2,633 | 2,633 | N/A | N/A |
| Debt Repayment | -353 | -267 | -223 | -310 | -289 |
| Other Financing Activity | 577 | 0 | 0 | 9,299 | 9,249 |
| Financing Cash Flow | $2,857 | $2,366 | $2,410 | $8,989 | $8,960 |
| Exchange Rate Effect | N/A | N/A | N/A | -17 | -21 |
| Beginning Cash Position | 1,775 | 1,775 | 1,775 | 727 | 727 |
| End Cash Position | 378 | 784 | 2,888 | 1,775 | 4,491 |
| Net Cash Flow | $-1,397 | $-991 | $1,113 | $1,048 | $3,764 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,620 | -3,331 | -1,301 | -8,411 | -6,240 |
| Capital Expenditure | -28 | -26 | -10 | -221 | -260 |
| Free Cash Flow | -4,648 | -3,357 | -1,311 | -8,632 | -6,500 |